NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.61
0.01 (0.86%)
At close: Aug 15, 2025, 1:12 PM

NovaBay Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.1M -9.64M -10.61M -5.82M
Depreciation & Amortization
381K 203K 483K 119K
Stock-Based Compensation
148K 291K 220K 1.15M
Other Working Capital
n/a 134K 388K -84K
Other Non-Cash Items
1.98M 4.26M 2.72M -4.62M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-595K 750K 533K -38K
Operating Cash Flow
-5.18M -4.13M -6.65M -9.19M
Capital Expenditures
-6K -19K -112K -52K
Cash Acquisitions
1.07M n/a n/a -11.99M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -11.99M
Investing Cash Flow
1.06M -19K -112K -12.04M
Debt Repayment
-1.49M 1.53M -105K 105K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
132K 384K 1.7M 16.68M
Financial Cash Flow
1.5M 1.91M 4.63M 16.79M
Net Cash Flow
-2.7M -2.24M -2.13M -4.45M
Free Cash Flow
-5.19M -4.15M -6.77M -9.24M